This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
coronavirus: Archive
Squeezing the Market: Riding the Rollercoaster of Short Squeeze Mania
by Andrew Rocco
Several stocks squeezed shorts Thursday. What does it mean for the market?
GMENegative Net Change QQQPositive Net Change AMCNegative Net Change ARKKPositive Net Change CVNAPositive Net Change BYNDNegative Net Change SPCENegative Net Change PLTRPositive Net Change
coronavirus e-commerce etfs investing reddit-stocks spac space
Bear of the Day: BioNTech (BNTX)
by Andrew Rocco
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
PFEPositive Net Change BNTXNegative Net Change
biotechnology biotechs coronavirus
How Did COVID Reshape the Labor Markets
by John Blank
The latest research focuses on retirees.
NVOPositive Net Change SAPPositive Net Change STLANegative Net Change
coronavirus economy
Boeing's Strength is Set to Continue Despite Q4 Loss
by Andrew Rocco
The world's largest aerospace company reported a Q4 loss of more than $600 million. Andrew Rocco breaks down why investors should look to the future and discount the past.
BANegative Net Change LMTNegative Net Change DALPositive Net Change UALPositive Net Change RKLBNegative Net Change
aerospace airlines coronavirus earnings transportation travel-leisure
3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying
by Sundeep Ganoria
We present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2023 despite an uncertain macro environment.
KMDAPositive Net Change ZYMEPositive Net Change
biotechnology biotechs cancer cell-therapy coronavirus immuno-therapy inflation medical
S&P 500 Overtakes Key 4,000 Level: Stocks to Watch
by Bryan Hayes
Buying pressure accelerated Tuesday afternoon, as all sectors found positive territory.
NFLXNegative Net Change MPCPositive Net Change ARRYNo Net Change
alt-energy consumer-discretionary coronavirus dividend-investing dividends earnings energy fang inflation interest-rate investing media oil-energy solar tech-stocks
Pfizer Earnings Preview: Growth & Diversification is Key
by Shaun Pruitt
Pfizer's (PFE) Q3 earnings report on Tuesday, November 1 will give insight into its ability to sustain growth from its Covid-19 vaccines. The company's ability to beat earnings expectations may rely on the growth of other business units during the quarter.
PFEPositive Net Change JNJNegative Net Change ABBVNegative Net Change
cancer coronavirus dividend-investing dividends earnings hospitals medical oncology-screening pharmaceuticals vaccines
The Meme Stock Resurgence: Is Now the Time to Buy?
by Bryan Hayes
Recent individual rallies suggest the meme stock movement is alive and well.
GMENegative Net Change BBBYPositive Net Change AMCNegative Net Change
coronavirus e-commerce earnings electronics gaming internet internet-content investing meme-stocks reddit-stocks social-media video-games
The Wind's at Your Back with This Shipping Sweetheart
by Bryan Hayes
Due to surges in global trade, shipping companies have witnessed a substantial improvement in terms of volumes and revenues.
EGLENegative Net Change
coronavirus e-commerce earnings electronics investing transportation
Survive the Financial Armageddon Using the Zacks Rank
by Bryan Hayes
Investors can use this system to find companies that are primed to surge in price - even when most stocks are falling.
SQMPositive Net Change
agriculture basic-materials coronavirus earnings investing